| NCT ID | NCT04504669 |
| Title | First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | AstraZeneca |
| Indications |
head and neck squamous cell carcinoma clear cell renal cell carcinoma |
| Therapies | |
| Age Groups: | adult senior |